A potential role for Galectin-3 inhibitors in the treatment of COVID-19

1111 days ago
@breakfast_dogs @VBruttel @BiophysicsFL Great points. https://t.co/JMv7sNdDlc https://t.co/ir9qAMEp0y
1117 days ago
@MariamAzeb @freethi52378078 Solid replies. Sometimes it takes a 'fool' (in the shakespearean sense) to state the obvious and make it plainly obvious.
1171 days ago
@Doblerin "Additionally, a key domain in the spike protein of β-coronaviridae, a genus which includes SARS-CoV2, is nearly identical in morphology to human Gal-3." https://t.co/F0ZXYA64ew
A potential role for #Galectin3 inhibitors in the treatment of #COVID19 [PeerJ] https://t.co/9pzsBYaHtm
RT @PaulElk79209403: @tampabaymyhome @drbeen_medical @kksheld Ironically, the red apple (pectin) is very promising in the fight against Cov…
1970 days ago
RT @kiranvelpula: 100 visitors to my 'A potential role for Galectin-3 inhibitors in the treatment of COVID-19' article published in #OpenAc…
RT @DannyJ40350853: @YoDoctorYo big news! The galectin-3 inhibitor TD139, a drug mentioned in the U of Illinois article, has begun clinical…
1974 days ago
@YoDoctorYo big news! The galectin-3 inhibitor TD139, a drug mentioned in the U of Illinois article, has begun clinical trials for COVID-19 treatment in the UK. https://t.co/066AsBlvKI https://t.co/cYJeusuoWh
A potential role for Galectin-3 inhibitors in the treatment of COVID-19 [PeerJ] ⁦@megtirrell⁩ ⁦@ScottGottliebMD⁩ ⁦@nytimes⁩ https://t.co/pWfczGyNhR
Potential role for Galectin-3 inhibitors, like Modified Citrus Pectin, in the treatment of COVID-19. https://t.co/tprxMtW6Px
RT @DanKomaromi: @nresearchnews @Kannan9900 @CommsBio Here is another connection between #ProstateCancer and #COVID19: Galectins in prosta…
1999 days ago
RT @DanKomaromi: @nresearchnews @Kannan9900 @CommsBio Here is another connection between #ProstateCancer and #COVID19: Galectins in prosta…
@nresearchnews @Kannan9900 @CommsBio Here is another connection between #ProstateCancer and #COVID19: Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities https://t.co/LucVCxP0gd A potential role for Galectin-3 inhibitors in the treatment of COVID-19 https://t.co/pljG9Q2luV
2020 days ago
RT @ECAWellness: https://t.co/AD67nmKCA8 Holy moly! This is exactly what I have talked about in my videos! Galectins are the key!
RT @ECAWellness: https://t.co/AD67nmKCA8 Holy moly! This is exactly what I have talked about in my videos! Galectins are the key!
UICOMP researchers were published in PeerJ this week. See what they have to say about an investigational cancer drug and COVID-19 -- https://t.co/KGOK8kMSfD https://t.co/hNTpkB1SV5
https://t.co/AD67nmKCA8 Holy moly! This is exactly what I have talked about in my videos! Galectins are the key!
2023 days ago
RT @thePeerJ: Just published in #PeerJ - A potential role for Galectin-3 inhibitors in the treatment of COVID-19 https://t.co/rFhcki5OU7 #c…
RT @Envirominer3: Article “Galectin-3 inhbitors in COVID-19” outlines the potential anti fibrotic Gal-3 inhibitor GR-MD-02 BelaPectin may h…
2023 days ago
RT @Envirominer3: Article “Galectin-3 inhbitors in COVID-19” outlines the potential anti fibrotic Gal-3 inhibitor GR-MD-02 BelaPectin may h…
RT @Envirominer3: Article “Galectin-3 inhbitors in COVID-19” outlines the potential anti fibrotic Gal-3 inhibitor GR-MD-02 BelaPectin may h…
RT @Envirominer3: Article “Galectin-3 inhbitors in COVID-19” outlines the potential anti fibrotic Gal-3 inhibitor GR-MD-02 BelaPectin may h…
RT @thePeerJ: Just published in #PeerJ - A potential role for Galectin-3 inhibitors in the treatment of COVID-19 https://t.co/rFhcki5OU7 #c…
2023 days ago
Article “Galectin-3 inhbitors in COVID-19” outlines the potential anti fibrotic Gal-3 inhibitor GR-MD-02 BelaPectin may have w/ #COVID Need trials ASAP! @GalectinGALT @SteveFDA @NIH #Covid_19 #ARDS #CytokineStorm @ArdsGlobal https://t.co/RvPqGoYdcS via @thePeerJ
Just published in #PeerJ - A potential role for Galectin-3 inhibitors in the treatment of COVID-19 https://t.co/rFhcki5OU7 #cellbiology #molecularbiology #COVID19 https://t.co/jYuWqFKCPM